EGOZINC-HC OINTMENT Canada - English - Health Canada

egozinc-hc ointment

pharmascience inc - zinc sulfate; hydrocortisone acetate - ointment - 0.5%; 0.5% - zinc sulfate 0.5%; hydrocortisone acetate 0.5% - anti-inflammatory agents

EGOZINC-HC SUPPOSITORY Canada - English - Health Canada

egozinc-hc suppository

pharmascience inc - zinc sulfate; hydrocortisone acetate - suppository - 10mg; 10mg - zinc sulfate 10mg; hydrocortisone acetate 10mg - anti-inflammatory agents

BORTEZOMIB injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

bortezomib injection, powder, lyophilized, for solution

pharmascience inc. - bortezomib (unii: 69g8bd63pp) (bortezomib - unii:69g8bd63pp) - bortezomib for injection , 3.5 mg/vial is indicated for the treatment of adult patients with multiple myeloma. bortezomib for injection is indicated for the treatment of adult patients with mantle cell lymphoma. bortezomib for injection is contraindicated in patients with hypersensitivity (not including local reactions) to bortezomib, boron, or mannitol. reactions have included anaphylactic reactions [ see adverse reactions (6.1) ]. bortezomib for injection is contraindicated for intrathecal administration. fatal events have occurred with intrathecal administration of bortezomib for injection. risk summary based on its mechanism of action [ see clinical pharmacology (12.1) ] and findings in animals, bortezomib for injection can cause fetal harm when administered to a pregnant woman. there are no  studies with the use of bortezomib for injection in pregnant women to inform drug-associated risks. bortezo

Erlotinib Pharmascience 100 mg film coated tablets Malta - English - Medicines Authority

erlotinib pharmascience 100 mg film coated tablets

pharmascience international ltd lampousas 1, 1095 nicosia , cyprus - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 100 mg - antineoplastic agents

Erlotinib Pharmascience 150 mg film coated tablets Malta - English - Medicines Authority

erlotinib pharmascience 150 mg film coated tablets

pharmascience international ltd lampousas 1, 1095 nicosia , cyprus - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 150 mg - antineoplastic agents

GANCICLOVIR- ganciclovir sodium injection, solution United States - English - NLM (National Library of Medicine)

ganciclovir- ganciclovir sodium injection, solution

pharmascience inc. - ganciclovir sodium (unii: 02l083w284) (ganciclovir - unii:p9g3ckz4p5) - ganciclovir 500 mg in 10 ml - ganciclovir injection is indicated for the treatment of cytomegalovirus (cmv) retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (aids) [see clinical studies (14.1)]. ganciclovir injection is indicated for the prevention of cmv disease in adult transplant recipients at risk for cmv disease [see clinical studies (14.2)]. ganciclovir injection ganciclovir injection is contraindicated in patients who have experienced a clinically significant hypersensitivity reaction (e.g., anaphylaxis) to ganciclovir, valganciclovir, or any component of the formulation. in animal studies, ganciclovir caused maternal and fetal toxicity and embryo-fetal mortality in pregnant mice and rabbits as well as teratogenicity in rabbits at exposures two times the exposure at the recommended human dose (rhd) [see data] . although pl

X-SEB PLUS CONDITIONING SHAMPOO Canada - English - Health Canada

x-seb plus conditioning shampoo

pharmascience inc - pyrithione zinc; salicylic acid - shampoo - 1%; 2% - pyrithione zinc 1%; salicylic acid 2% - miscellaneous local anti-infectives

HEMORRHOIDAL OINTMENT Canada - English - Health Canada

hemorrhoidal ointment

pharmascience inc - pramoxine hydrochloride; zinc sulfate monohydrate - ointment - 1.0%; 0.5% - pramoxine hydrochloride 1.0%; zinc sulfate monohydrate 0.5% - antipruritics and local anesthetics

HEMORRHOIDAL OINTMENT Canada - English - Health Canada

hemorrhoidal ointment

pharmascience inc - pramoxine hydrochloride; zinc sulfate - ointment - 1%; 0.5% - pramoxine hydrochloride 1%; zinc sulfate 0.5% - antipruritics and local anesthetics